Market Place
Sourcing Support
Gland Pharma`s Generic Angiotensin II Receives Approval in the U.S.
14 Nov 2023 //
EMA
FDA Confirms Paragraph IV Patent Litigation for Angiotensin II Acetate
09 Feb 2022 //
FDA
AZ bags two extensions in latest CHMP decisions
01 Jul 2019 //
PHARMATIMES
La Jolla grabs $125M royalty deal to back drug launch, fund R&D
12 May 2018 //
ENDPTS
FDA approves drug to treat dangerously low blood pressure
22 Dec 2017 //
BIOSPECTRUM
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.